...
首页> 外文期刊>Polymers >Biphasic Polyurethane/Polylactide Sponges Doped with Nano-Hydroxyapatite (nHAp) Combined with Human Adipose-Derived Mesenchymal Stromal Stem Cells for Regenerative Medicine Applications
【24h】

Biphasic Polyurethane/Polylactide Sponges Doped with Nano-Hydroxyapatite (nHAp) Combined with Human Adipose-Derived Mesenchymal Stromal Stem Cells for Regenerative Medicine Applications

机译:掺杂有纳米羟基磷灰石(NHAP)的双相聚氨酯/聚乳糖海绵联合人脂肪衍生的间充质基质干细胞,用于再生医学应用

获取原文
           

摘要

Cartilage and bone tissue injuries are common targets in regenerative medicine. The degeneration of cartilage tissue results in tissue loss with a limited ability to regenerate. However, the application of mesenchymal stem cells in the course of such condition makes it possible to manage this disorder by improving the structure of the remaining tissue and even stimulating its regeneration. Nevertheless, in the case of significant tissue loss, standard local injection of cell suspensions is insufficient, due to the low engraftment of transplanted cells. Introduction of mesenchymal stem cells on the surface of a compatible biomaterial can be a promising tool for inducing the regeneration by both retaining the cells at the desired site and filling the tissue gap. In order to obtain such a cell-biomaterial hybrid, we developed complex, biphasic polymer blend biomaterials composed of various polyurethane (PU)-to-polylactide (PLA) ratios, and doped with different concentrations of nano-hydroxyapatite (nHAp). We have determined the optimal blend composition and nano-hydroxyapatite concentration for adipose mesenchymal stem cells cultured on the biomaterial. We applied biological in vitro techniques, including cell viability assay, determination of oxidative stress factors level, osteogenic and chondrogenic differentiation potentials as well as cell proteomic analysis. We have shown that the optimal composition of biphasic scaffold was 20:80 of PU:PLA with 20% of nHAp for osteogenic differentiation, and 80:20 of PU:PLA with 10% of nHAp for chondrogenic differentiation, which suggest the optimal composition of final biphasic implant for regenerative medicine applications.
机译:软骨和骨组织损伤是再生医学中的常见目标。软骨组织的退化导致组织损失具有有限的再生能力。然而,在这种病症的过程中,间充质干细胞的应用使得可以通过改善剩余组织的结构甚至刺激其再生来管理这种疾病。然而,在显着的组织损失的情况下,由于移植细胞的低植入,标准局部注射细胞悬浮液的局部注射不足。间充质干细胞在相容生物材料表面上的引入可以是通过在所需部位处保留细胞并填充组织间隙来诱导再生的有希望的工具。为了获得这种细胞生物材料杂种,我们开发了由各种聚氨酯(PU)-TO-聚酰胺(PLA)比组成的复杂的双相聚合物共混生物材料,并掺杂有不同浓度的纳米羟基磷灰石(NHAP)。我们已经确定了在生物材料上培养的脂肪间充质干细胞的最佳共混物组合物和纳米羟基磷灰石浓度。我们应用生物体外技术,包括细胞活力测定,测定氧化应激因子水平,骨质植物和软骨内分化电位以及细胞蛋白质组学分析。我们已经表明,双相支架的最佳组成为20:80 PU:PLA,具有20%的NHAP用于成骨分化,80:20的PU:PLA,具有10%的NHAP用于软骨分化,这表明了最佳的组成最终双相植入物用于再生医学应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号